Orbimed Advisors Llc - Dec 31, 2024 SCHEDULE 13G Report for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED CAPITAL LLC
Security
ADC Therapeutics SA Common Shares, par value CHF 0.08 per share
Symbol
ADCT
Shares outstanding
95.5M shares
Disclosed Ownership
3.44M shares
Ownership
3.6%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 04:35 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)